Dc. Ansardi et al., ENCAPSIDATION AND SERIAL PASSAGE OF A POLIOVIRUS REPLICON WHICH EXPRESSES AN INACTIVE 2A PROTEINASE, Journal of virology, 69(2), 1995, pp. 1359-1366
The multiple roles of the viral proteinase 2A in poliovirus replicatio
n have been difficult to assess because, to date, it has not been poss
ible to isolate and characterize a viral genome with an inactive 2A(pr
o). We have previously reported that a poliovirus replicon containing
an inactive 2A(pro) by virtue of a change at amino acid 109 from a cys
teine to a serine (C109S) was replication competent when transfected i
nto cells previously infected with vaccinia virus (R. Pal-Ghosh and C.
D. Morrow, J. Virol. 67:4621-4629, 1993). To further develop this sys
tem, we have used a poliovirus replicon which contains the human immun
odeficiency virus type 1 (HIV-1) gag gene positioned between nucleotid
es 1174 and 2470 of the poliovirus genome and have engineered a second
mutation within this replicon to change the codon for amino acid 109
of the 2A(pro) from cysteine to serine (2AC109S). Transfection of this
replicon into cells previously infected with vaccinia virus results i
n the replication and expression of a protein with a molecular mass co
nsistent with that of a P1-HIV-1 Gag-2A fusion protein. Using a recent
ly described complementation system which relies on the capacity of a
recombinant vaccinia virus (VV-P1) to provide the capsid precursor (P1
) in trans (D. C. Ansardi, D. C. Porter, and C. D. Morrow, J. Virol. 6
7:3684-3690, 1993; and D. C. Porter, D. C. Ansardi, W. S. Choi, and C.
D. Morrow J. Virol. 67:3712-3719, 1993), we have encapsidated this re
plicon containing the 2AC109S mutation. By using reverse transcription
PCR, we demonstrated that after 15 serial passages the encapsidated r
eplicon still contained the 2AC109S mutation. Infection of cells with
a stock of encapsidated replicon, either in the presence or in the abs
ence of vaccinia virus, resulted in the expression of the P1-HIV-1 Gag
-2A fusion protein. Expression of the P1-HIV-1 Gag fusion protein in c
ells infected with the encapsidated replicon containing the 2AC109S mu
tation was reduced compared with the expression of P1-HIV-1 Gag in tho
se cells infected with a replicon containing a wild type 2A gene. The
protein expression and replication of the replicon RNA in cells contai
ning the 2AC109S mutation was maintained for a longer period of time t
han for the replicons containing the wild-type 2A gene, possibly becau
se of a reduced cytopathic effect. Coinfection of cells with the encap
sidated replicon containing the 2AC109S mutation and wild-type poliovi
rus resulted in the further processing of the P1-HIV-1 Gag-2A fusion p
rotein to produce the P1-HIV-1 Gag fusion protein, demonstrating that
the protease activity of 2A can be supplied in part in trans. This stu
dy is the first to describe a poliovirus genome (or replicon) that con
tains an enzymatically inactive P2 or P3 gene product. On the basis of
this study, we conclude that the protease activity of 2A is not essen
tial for viral RNA replication, although 2A is required for high-level
replication and expression.